Mammalian Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025

Description

Persistence Market Research has recently released a comprehensive report on the global Mammalian Cell Banking Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Mammalian Cell Banking Market Size (2025E): USD 567.0 Mn
Projected Market Value (2032F): USD 1,418.8 Mn
Global Market Growth Rate (CAGR 2025 to 2032): 14.0%

Mammalian Cell Banking Market - Report Scope:

The mammalian cell banking market includes the development, storage, and maintenance of cell lines derived from mammalian cells, which are essential for biologics manufacturing, gene therapy, and vaccine production. Cell banks ensure consistency, quality, and safety in the production of biopharmaceuticals. As demand for monoclonal antibodies, cell and gene therapies, and personalized medicine increases globally, mammalian cell banking has become a critical component in ensuring reliable and scalable production processes.

Market Growth Drivers:

The mammalian cell banking market is experiencing strong growth driven by several influential factors. A major driver is the rising demand for biologics and biosimilars, which require stable and well-characterized mammalian cell lines for production. The increasing focus on personalized medicine and cell & gene therapies has further accelerated the need for secure and high-quality cell banking systems. Technological advancements in cell line development, such as CRISPR-based engineering and high-throughput screening, are also contributing to market expansion. In addition, regulatory support for the use of Good Manufacturing Practices (GMP) in cell banking enhances product quality and compliance, propelling the market forward.

Market Restraints:

Despite its growth potential, the mammalian cell banking market faces some challenges. High initial investment and operational costs associated with establishing GMP-compliant facilities can be a significant barrier, especially for small and mid-sized enterprises. Moreover, the complex and time-consuming regulatory approval processes for new cell lines can delay product development. There are also risks associated with contamination, genetic drift, or variability in long-term storage, which necessitate stringent quality control and monitoring systems, adding to the cost and complexity.

Market Opportunities:

The mammalian cell banking market presents numerous opportunities for expansion and innovation. The increasing number of clinical trials involving biologics and advanced therapies, particularly in oncology and rare diseases, is creating demand for diverse and reliable cell banks. Emerging markets in Asia-Pacific and Latin America are rapidly expanding their biopharmaceutical manufacturing capabilities, offering new business prospects. In addition, collaborations between biopharma companies and CROs to outsource cell banking services are on the rise, enabling scalability and efficiency. Investment in automation and digital technologies, such as AI-driven quality control and digital biobanking platforms, also opens doors for greater standardization and operational excellence.

Key Questions Answered in the Report:

What are the primary factors driving the global mammalian cell banking market's growth?
Which cell types and applications are dominating the mammalian cell banking landscape?
How are biopharmaceutical trends shaping future cell banking strategies?
Who are the key players in the mammalian cell banking market, and what strategies are they adopting?
What are the growth opportunities in emerging regions?

Competitive Intelligence and Business Strategy:

Leading companies in the mammalian cell banking market, such as Eurofins DiscoverX Corporation, Merck KGaA, Sartorius Stedim BioOutsource Limited, Charles River Laboratories, and Lonza Group Ltd, are focusing on expanding their GMP-compliant manufacturing facilities and enhancing service portfolios to meet global biopharma demand. Strategic partnerships with biotech firms and academic institutes, along with R&D investments in innovative cell line technologies, are key to maintaining a competitive edge. Companies are also emphasizing quality assurance, contamination prevention, and regulatory alignment to boost client confidence and streamline product development pipelines.

Companies Covered in This Report:

Eurofins DiscoverX Corporation
Merck KGaA
Sartorius Stedim BioOutsource Limited
Charles River Laboratories
Altogen Labs
Abzena Ltd
Northway Biotechpharma
Lonza Group Ltd
VIRUSURE
Selexis SA
Takara Bio Inc

Key Segments Covered in Manufacturing of Industry Research:

Cell Type:

CHO
BHK
NS0
YB2/0 & P2/0
HEK293 & Derivatives
HELA

Technology:

Application:

MCB (Master Cell Bank)
WCB (Working Cell Bank)
EoP (End of Production)
R&D CB (Research & Development Cell Bank)

End User:

Academic & Research Institutes
Biopharmaceutical Companies
CROs (Contract Research Organizations)

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East & Africa (MEA)

Product Code: PMRREP31663

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends

4. Key Success Factors

4.1. Pipeline Assessment
4.2. Value chain Analysis
4.3. Key Promotional Strategies, By Key Manufacturers
4.4. Regulatory Landscape
4.5. PESTLE Analysis
4.6. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure
- 5.1.3. Global Cell Banking Outsourcing Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Key Player's Historic Growth
- 5.2.2. Market Consolidation Activities
- 5.2.3. Increasing Geriatric Population
- 5.2.4. Rising Cases of Cancer
- 5.2.5. Growing Preference of Mammalian Cell Banking
- 5.2.6. Increased R&D investments by Government
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Cell
- 6.1.2. By Technology
- 6.1.3. By Application
- 6.1.4. By End User
- 6.1.5. By Region
6.2. 2022 Market Scenario

7. Global Mammalian Cell Banking Market Outlook, 2019-2032

7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Cell

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2019-2024
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2025-2032
8.4. Market Attractiveness Analysis By Cell

9. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Technology

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Technology, 2019-2024
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2025-2032
9.4. Market Attractiveness Analysis By Technology

10. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Application

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2024
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2025-2032
10.4. Market Attractiveness Analysis By Application

11. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By End User

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By End User, 2019-2024
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025-2032
- 11.3.1. Academic & Research Institute
- 11.3.2. Biopharmaceutical Companies
- 11.3.3. CROs
11.4. Market Attractiveness Analysis By End User

12. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Region

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. East Asia
- 12.3.5. South Asia
- 12.3.6. Oceania
- 12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13. North America Mammalian Cell Banking Market Outlook, 2019-2032

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 13.3.1. By Country
  - 13.3.1.1. U.S.
  - 13.3.1.2. Canada
13.4. Market Attractiveness Analysis
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. U.S. Mammalian Cell Banking Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.2. Canada Mammalian Cell Banking Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy

14. Latin America Mammalian Cell Banking Market Outlook, 2019-2032

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 14.3.1. By Country
  - 14.3.1.1. Mexico
  - 14.3.1.2. Brazil
  - 14.3.1.3. Argentina
  - 14.3.1.4. Rest of Latin America
14.4. Market Attractiveness Analysis
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. Mexico Mammalian Cell Banking Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.2. Brazil Mammalian Cell Banking Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.3. Argentina Mammalian Cell Banking Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy

15. Europe Mammalian Cell Banking Market Outlook, 2019-2032

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 15.3.1. By Country
  - 15.3.1.1. Italy
  - 15.3.1.2. Germany
  - 15.3.1.3. U.K
  - 15.3.1.4. France
  - 15.3.1.5. Spain
  - 15.3.1.6. BENELUX
  - 15.3.1.7. Nordic Countries
  - 15.3.1.8. Russia
  - 15.3.1.9. Rest of Europe
15.4. Market Attractiveness Analysis
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. Italy Mammalian Cell Banking Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.2. Germany Mammalian Cell Banking Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.3. U.K. Mammalian Cell Banking Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.4. France Mammalian Cell Banking Market Analysis
  - 15.8.4.1. Introduction
  - 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.5. Spain Mammalian Cell Banking Market Analysis
  - 15.8.5.1. Introduction
  - 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.6. BENELUX Mammalian Cell Banking Market Analysis
  - 15.8.6.1. Introduction
  - 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
  - 15.8.7.1. Introduction
  - 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.8. Russia Mammalian Cell Banking Market Analysis
  - 15.8.8.1. Introduction
  - 15.8.8.2. Market Analysis and Forecast by Market Taxonomy

16. South Asia Mammalian Cell Banking Market Outlook, 2019-2032

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Indonesia
  - 16.3.1.3. Malaysia
  - 16.3.1.4. Thailand
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Cell
16.4. Market Attractiveness Analysis
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. India Mammalian Cell Banking Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.2. Indonesia Mammalian Cell Banking Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.3. Malaysia Mammalian Cell Banking Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.4. Thailand Mammalian Cell Banking Market Analysis
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast by Market Taxonomy

17. East Asia Mammalian Cell Banking Market Outlook, 2019-2032

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 17.3.1. By Country
  - 17.3.1.1. China
  - 17.3.1.2. Japan
  - 17.3.1.3. South Korea
17.4. Market Attractiveness Analysis
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
- 17.8.1. China Mammalian Cell Banking Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.2. Japan Mammalian Cell Banking Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.3. South Korea Mammalian Cell Banking Market Analysis
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy

18. Oceania Mammalian Cell Banking Market 2019-2024 and Forecast 2025-2032

18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 18.3.1. By Country
  - 18.3.1.1. Australia
  - 18.3.1.2. New Zealand
18.4. Market Attractiveness Analysis
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
- 18.8.1. Australia Mammalian Cell Banking Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.2. New Zealand Mammalian Cell Banking Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy

19. Middle East and Africa (MEA) Mammalian Cell Banking Market Outlook, 2019-2032

19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 19.3.1. By Country
  - 19.3.1.1. GCC Countries
  - 19.3.1.2. Turkey
  - 19.3.1.3. South Africa
  - 19.3.1.4. North Africa
  - 19.3.1.5. Rest of Middle East and Africa
19.4. Market Attractiveness Analysis
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
- 19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
  - 19.8.1.1. Introduction
  - 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 19.8.2. Turkey Mammalian Cell Banking Market Analysis
- 19.8.3. South Africa Mammalian Cell Banking Market Analysis
- 19.8.4. North Africa Mammalian Cell Banking Market Analysis

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Presence Analysis
- 20.3.1. By Regional Footprint of Players
- 20.3.2. Cell Footprint of Players
- 20.3.3. Channel Footprint of Players

21. Competition Analysis

21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
- 21.3.1. Eurofins DiscoverX Corporation
  - 21.3.1.1. Overview
  - 21.3.1.2. Product & Services Portfolio
  - 21.3.1.3. Key Financials
  - 21.3.1.4. SWOT Analysis
  - 21.3.1.5. Key Developments
  - 21.3.1.6. Sales Footprint
  - 21.3.1.7. Strategy Overview
    - 21.3.1.7.1. Marketing Strategy
    - 21.3.1.7.2. Product Strategy
    - 21.3.1.7.3. Channel Strategy
- 21.3.2. Merck KGaA
- 21.3.3. Sartorius Stedim BioOutsource Limited.
- 21.3.4. Charles River Laboratories
- 21.3.5. Altogen Labs
- 21.3.6. Abzena Ltd
- 21.3.7. Northway Biotechpharma
- 21.3.8. Lonza Group Ltd
- 21.3.9. VIRUSURE
- 21.3.10. Selexis SA
- 21.3.11. Sigma-Aldrich
- 21.3.12. Takara Bio Inc

Mammalian Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032